EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement

Ayman R Fath, Amro Aglan, Osamah Altaee, Hendre Fichardt, Hend Mansoor, Ahmed Almomani, Muhammad Hammadah, Ariel Vinas, Hemal Nayak, Hani Jneid, Marwan Saad, Islam Y Elgendy

JACC: Clinical Electrophysiology · 2024-12 · 10 (12) · 2701-2710

DOI: 10.1016/j.jacep.2024.08.005 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC: Clinical Electrophysiology, 2024-12. Verfasst von Ayman R Fath und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA. Electronic address: aymanfath.md@gmail.com. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Atrial Fibrillation, Anticoagulants, Warfarin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic Heart DiseaseAtrial FibrillationAnticoagulantsWarfarinHeart Valve Prosthesis ImplantationMitral ValveHumansFemaleMaleAgedMiddle AgedAdministration, OralBioprosthesisHeart Valve ProsthesisPostoperative Complications

Stichwörter der Autor:innen

atrial fibrillationbioprosthetic mitral valve replacementdirect oral anticoagulantrheumatic heart diseasevitamin K antagonistwarfarin

Substanzen

AnticoagulantsWarfarin

Autor:innen und Institutionen

  • Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA. Electronic address: aymanfath.md@gmail.com.
  • Cardiology Department, Westchester Medical Center, New York Medical College, Valhalla, New York, USA.
  • Department of Pharmacy, Practice and Science, College of Pharmacy University of Kentucky, Lexington, Kentucky, USA.
  • Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA.
  • Division of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Lifespan Cardiovascular Institute, Providence, Rhode Island, USA; Department of Cardiology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Zitieren

APA

Fath, A. R., Aglan, A., Altaee, O., Fichardt, H., Mansoor, H., Almomani, A., Hammadah, M., Vinas, A., Nayak, H., Jneid, H., Saad, M., & Elgendy, I. Y. (2024). Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC: Clinical Electrophysiology, 10(12), 2701-2710. https://doi.org/10.1016/j.jacep.2024.08.005

Vancouver

Fath AR, Aglan A, Altaee O, Fichardt H, Mansoor H, Almomani A, et al. Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC: Clinical Electrophysiology. 2024;10(12):2701-2710. doi:10.1016/j.jacep.2024.08.005

BibTeX
@article{Fath2024,
  author = {Fath, Ayman R and Aglan, Amro and Altaee, Osamah and Fichardt, Hendre and Mansoor, Hend and Almomani, Ahmed and Hammadah, Muhammad and Vinas, Ariel and Nayak, Hemal and Jneid, Hani and Saad, Marwan and Elgendy, Islam Y},
  title = {Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {12},
  pages = {2701--2710},
  doi = {10.1016/j.jacep.2024.08.005}
}
Kostenlos starten →